ArticlebioRxiv : the preprint server for biology2025
Symptomatic treatment by a BBB-permeable AAV engineered to restore TDP-43 function slows motor neuron disease and prevents paralysis.
Aswathy Peethambaran Mallika et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.